bioMérieux

Update in progress

BIM.PA (Paris)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases worldwide. It operates through Clinical Applications and Industrial Applications segments. The company offers culture media (CHROMID RANGE), monitoring systems, and diagnostic platforms such as BACT/ALERT VIRTUO, BIOFIRE, SPOTFIRE, VITEK MS, VITEK 2, API RANGE, ETEST, and EPISEQ CS, plus VIDAS and Vision Suite software. It also provides ARGENE PCR tests, extraction reagents, and training services. Founded 1963, based in Marcy-l'Étoile, France.

Company score

Sentiment: 0.44; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.08; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.30; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.07; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.29; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive